Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  ACS Chemical Neuroscience

• Publication date

  2011-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/cn200001kPMID 22778873PMCID PMC3369758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23].

  2011cited by this paper
• Point Mutations in Aβ Result in the Formation of Distinct Polymorphic Aggregates in the Presence of Lipid Bilayers

  2011cited by this paper
• Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated.

  2010cited by this paper
• Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23.

  2010cited by this paper
• The turn formation at positions 22 and 23 in the 42‐mer amyloid β peptide: The emerging role in the pathogenesis of Alzheimer's disease

  2010cited by this paper
• Amyloid-beta membrane binding and permeabilization are distinct processes influenced separately by membrane charge and fluidity.

  2009cited by this paper
• Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils.

  2009cited by this paper
• Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure

  2009cited by this paper
• Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils

  2008cited by this paper
• Amyloid toxicity is independent of polypeptide sequence, length and chirality.

  2008cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models*

  2007cited by this paper
• Polymorphism in the intermediates and products of amyloid assembly.

  2007cited by this paper
• Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Similarities in the thermodynamics and kinetics of aggregation of disease‐related Aβ(1–40) peptides

  2007cited by this paper
• Physiochemical characterization of the Alzheimer's disease‐related peptides Aβ1–42Arctic and Aβ1–42wt

  2006cited by this paper
• Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt.

  2006cited by this paper
• Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.

  2006cited by this paper
• Single Chain Fv Antibodies against the 25−35 Aβ Fragment Inhibit Aggregation and Toxicity of Aβ42†

  2006cited by this paper
• Autoinsertion of soluble oligomers of Alzheimer's Aβ(1–42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

  2005cited by this paper
• Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

  2005cited by this paper
• Single chain variable fragments against β-amyloid (Aβ) can inhibit Aβ aggregation and prevent Aβ-induced neurotoxicity

  2004cited by this paper
• Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

  2004cited by this paper
• Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.

  2004cited by this paper
• The interaction of proteins with solid surfaces.

  2004cited by this paper
• Effect of different anti-Abeta antibodies on Abeta fibrillogenesis as assessed by atomic force microscopy.

  2004cited by this paper
• Effect of Different Anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force Microscopy

  2004cited by this paper
• Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.

  2003cited by this paper
• In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis*

  2003cited by this paper
• Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

  2003cited by this paper
• Amyloid -protein (A) assembly: A40 and A42 oligomerize through distinct pathways

  2003cited by this paper
• Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

  2003cited by this paper
• Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.

  2002cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• The Arctic Alzheimer mutation enhances sensitivity to toxic stress in human neuroblastoma cells.

  2002cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS*

  2001cited by this paper
• Comparison of the aggregation properties, secondary structure and apoptotic effects of wild‐type, Flemish and Dutch N‐terminally truncated amyloid β peptides

  2001cited by this paper
• In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

  2001cited by this paper
• Pathogenic effects of D23N Iowa mutant amyloid beta -protein.

  2001cited by this paper
• Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein*

  2001cited by this paper
• Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors.

  2000cited by this paper
• In-situ atomic force microscopy study of beta-amyloid fibrillization.

  2000cited by this paper
• Oligomerization of β-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types

  2000cited by this paper
• Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation Inhibitors

  2000cited by this paper
• Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types.

  2000cited by this paper
• Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

  2000cited by this paper
• In situ atomic force microscopy study of Alzheimer’s β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation

  1999cited by this paper
• Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein.

  1999cited by this paper
• In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation.

  1999cited by this paper
• Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• From the globular to the fibrous state: protein structure and structural conversion in amyloid formation

  1998cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease.

  1997cited by this paper
• Aggregation and Metal‐Binding Properties of Mutant Forms of the Amyloid Aβ Peptide of Alzheimer's Disease

  1996cited by this paper
• Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

  1993cited by this paper

• Macromolecular crowding in solution alters huntingtin interaction and aggregation at interfaces.

  2021cites this paper
• Cross-seeding Controls Aβ Fibril Populations and Resulting Function

  2021cites this paper
• Phosphomimetic Mutations Impact Huntingtin Aggregation in the Presence of a Variety of Lipid Systems.

  2020cites this paper
• The Role of Aβ in the Development of Alzheimer’s Disease and its Mechanisms

  2020cites this paper
• Colorimetric Detection of Mutant β-Amyloid(1-40) Membrane-Active Aggregation with Biosensing Vesicles.

  2019cites this paper
• Molecular Dynamics simulations applied to structural and dynamical transitions of the HTT protein: A review.

  2019cites this paper
• Challenges in understanding the structure/activity relationship of Aβ oligomers

  2019cites this paper
• Acetylation of Aβ40 alters aggregation in the presence and absence of lipid membranes.

  2019cites this paper
• Shedding light on aberrant interactions – a review of modern tools for studying protein aggregates

  2018cites this paper
• Shedding light on aberrant interactions

  2018cites this paper
• Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

  2017cites this paper
• Cholesterol Modifies Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.

  2016cites this paper
• A Detailed Analysis of the Morphology of Fibrils of Selectively Mutated Amyloid β (1-40).

  2016cites this paper
• The clearance of misfolded proteins in neurodegenerative diseases by zinc metalloproteases: An inorganic perspective

  2014cites this paper
• Local interactions influence the fibrillation kinetics, structure and dynamics of Aβ(1-40) but leave the general fibril structure unchanged.

  2014cites this paper
• Biophysical Insights into How Surfaces, Including Lipid Membranes, Modulate Protein Aggregation Related to Neurodegeneration

  2013cites this paper
• Specific domains of Aβ facilitate aggregation on and association with lipid bilayers.

  2013cites this paper
• The role of amyloidogenic protein oligomerization in neurodegenerative disease

  2013cites this paper
• Nucleation and growth of elastin-like peptide fibril multilayers: an in situ atomic force microscopy study

  2011cites this paper
• The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

  2011cites this paper